Blumenthal, Deborah T; Gorlia, Thierry; Gilbert, Mark R; Kim, Michelle M; Burt Nabors, L; Mason, Warren P; Hegi, Monika E; Zhang, Peixin; Golfinopoulos, Vassilis; Perry, James R; Hyun Nam, Do; Erridge, Sara C; Corn, Benjamin W; Mirimanoff, René O; Brown, Paul D; Baumert, Brigitta G; Mehta, Minesh P; van den Bent, Martin J; Reardon, David A; Weller, Michael; Stupp, Roger (2017). Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG. Neuro-Oncology, 19(8):1119-1126.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
0 downloads since deposited on 09 Nov 2017
0 downloads since 12 months
0 downloads since 12 months
Additional indexing
Item Type: | Journal Article, refereed, original work |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Health Sciences > Oncology
Health Sciences > Neurology (clinical) Life Sciences > Cancer Research |
Language: | English |
Date: | 1 August 2017 |
Deposited On: | 09 Nov 2017 07:26 |
Last Modified: | 26 Jan 2022 13:55 |
Publisher: | Oxford University Press |
ISSN: | 1522-8517 |
OA Status: | Closed |
Free access at: | Publisher DOI. An embargo period may apply. |
Publisher DOI: | https://doi.org/10.1093/neuonc/nox025 |
PubMed ID: | 28371907 |
Users (please log in): Suggest update or correction for this item
For submitters/editors: Edit metadata
Permanent URL: https://doi.org/10.5167/uzh-141038
Download
- Content: Published Version
- Permission: Download for registered users
Links
Authors, Affiliations, Collaborations

Tel Aviv University, Tel Aviv-Yafo, Israel
European Organisation for Research and Treatment of Cancer, Brussels, Belgium
National Institutes of Health, Bethesda, Bethesda, United States
Tel Aviv University, Tel Aviv-Yafo, Israel
Tel Aviv University, Tel Aviv-Yafo, Israel
National Institutes of Health, Bethesda, Bethesda, United States
The University of Alabama at Birmingham, Birmingham, United States
University of Toronto, Toronto, Canada
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
NRG Oncology Statistics and Data Management Center, Philadelphia, United States
University of Toronto, Toronto, Canada
SungKyunKwan University, School of Medicine, Suwon, South Korea
Tel Aviv University, Tel Aviv-Yafo, Israel
European Organisation for Research and Treatment of Cancer, Brussels, Belgium
National Institutes of Health, Bethesda, Bethesda, United States
Edinburgh Cancer Centre, Edinburgh, United Kingdom
National Institutes of Health, Bethesda, Bethesda, United States
Edinburgh Cancer Centre, Edinburgh, United Kingdom
The University of Alabama at Birmingham, Birmingham, United States
University of Toronto, Toronto, Canada
Universität Bonn, Bonn, Germany
University of Toronto, Toronto, Canada
Universität Bonn, Bonn, Germany
Tel Aviv University, Tel Aviv-Yafo, Israel
Maastricht University, Maastricht, Netherlands
Maastricht University, Maastricht, Netherlands
European Organisation for Research and Treatment of Cancer, Brussels, Belgium
Miami Cancer Institute, Coral Gables, United States
Miami Cancer Institute, Coral Gables, United States
Erasmus MC, Rotterdam, Netherlands
Tel Aviv University, Tel Aviv-Yafo, Israel
Harvard Medical School, Boston, United States
Harvard Medical School, Boston, United States
University of Zurich, Zurich, Switzerland
Tel Aviv University, Tel Aviv-Yafo, Israel
University of Zurich, Zurich, Switzerland
University of Zurich, Zurich, Switzerland